Gynecologic Oncology Group (GOG) performance status , , 
Patients must have Gynecologic Oncology Group (GOG) performance status , , or 
Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists; in general, this would refer to any active GOG Phase III protocol or Rare Tumor protocol for the same patient population
Patients must have a Gynecologic Oncology Group (GOG) performance grade of , , or 
Gynecologic Oncology Group (GOG) performance status > 
Gynecologic Oncology Group (GOG) or Eastern Cooperative Oncology Group (ECOG) performance status =<  or Karnofsky scale (KPS) =< %
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Gynecologic Oncology Group (GOG) performance status , , or 
Patients must have Gynecologic Oncology Group (GOG) performance status , , or 
Gynecologic Oncology Group (GOG) performance status =< 
PHASE I: Patients must have a Gynecologic Oncology Groups (GOG) performance status of , , or 
Unlimited number of prior treatment lines, provided Gynecologic Oncology Group (GOG)/Eastern Cooperative Oncology Group (ECOG) status is -
Patients must have a Gynecologic Oncology Group (GOG) performance status of  or 
Gynecologic Oncology Group (GOG) performance status =< 
Gynecologic Oncology Group (GOG) Performance Status of , , or 
Gynecologic Oncology Group (GOG) performance status >= 
Gynecologic Oncology Group (GOG) performance status of  or 
Patients must have a Gynecologic Oncology Group (GOG) performance status of -
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Patients with Gynecologic Oncology Group (GOG) performance status of  or 
Gynecologic Oncology Group (GOG) performance status of  to .
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Patients must not be eligible for a higher priority NRG clear cell protocol (Gynecologic Oncology Group [GOG]-); rare patients ineligible for GOG- may be eligible for this trial without prior treatment on dasatinib therapy (e.g. they have been deemed allergic to dasatinib)
Gynecologic Oncology Group (GOG) performance status =< 
Patients must have Gynecologic Oncology Group (GOG) performance status , , or 
Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists            \r\n* In general, this would refer to any active GOG phase III or rare tumor protocol for the same patient population
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Peritoneal dialysis catheter implantation is identical to that from the Gynecologic Oncology Group (GOG)  Protocol and revised from the GOG Surgical Procedures Manual
Patients must have a Gynecologic Oncology Group (GOG) performance status of , , or 
Patient must have Gynecologic Oncology Group (GOG) performance status of , , or 
Patients must have a Gynecologic Oncology Group (GOG) performance grade of , , or 
Gynecologic Oncology Group (GOG) performance status =< 
